Alzheimer's Disease — Perspective from Political Science: Public Policy Issues

Abstract

The paper outlines the policy context and summarizes the numerous policy issues that AD raises from the more generic to the unique. It posits that strong public fears of AD and its future prevalence projections and costs, raise increasingly difficult policy dilemmas. After reviewing the costs in human lives and money and discussing the latest U.S. policy initiatives, the paper presents two policy areas as examples the demanding policy decisions we face. The first focuses on the basic regulatory function of protecting the public from those who would exploit these fears. The second centers on the well-debated issues of advance directives and euthanasia that surround AD. Although more dialogue, education and research funding are needed to best serve the interests of AD patients and families as well as society at large, this will be challenging because of the strong feelings and divisions AD engenders.

Get full access to this article

View all access options for this article.

References

J. P. W.

Bynum

, “The Long Reach of Alzheimer's Disease: Patients, Practice, and Policy,” Alzheimer's Disease: Patients, Practice, and Policy, Health Affairs 33, no. 4 (2014): 534-40. Also see

R. H.

Blank

, Social and Public Policy of Alzheimer's Disease in the United States (London: Palgrave Macmillan, 2019).

Alzheimer's Association and Centers for Disease Control and Prevention, The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013–2018 (Chicago, IL: Alzheimer's Association, 2013).

Alzheimer's Association, “Alzheimer's Disease State Plans,” 2016, available at <http://act.alz.org/site/PageNavigator/state_plans.html> (last visited July 25, 2018).

Hoffman

, “Looking at the Future of Alzheimer's Disease Policy,” Health Affairs Health Policy Lab, 2015, available at <http://healthaffairs.org/blog/2015/07/14/looking-at-the-future-of-alzheimers-disease-policy/> (last visited July 25, 2018).

Sinclair

, “The Financial and Emotional Toll of America's Alzheimer's Problem,” 2016, <http://finance.yahoo.com/news/alzheimers-most-expensive-disease-caregivers-cost-190758660.html;_ylt=_A0LEV12541VYQZoAsQFXN-yoA;_ylu=X3oDMTEyaTkzYXJyBGNvbG8DYmYxBHBvcwMxBHZ0aWQDQjMyMTlfMQRzZWMDc3I-> (last visited July 25, 2018).

Alzheimer's Association, “Alzheimer's Disease Facts and Figures,” Alzheimer's & Dementia 12 (2016), available at <https://www.sciencedirect.com/science/article/pii/S1552526016000856 (last visited August 28, 2018).

Weuve

et al ., “Deaths in the United States among Persons with Alzheimer's Disease, 2010–2050,” Alzheimer's & Dementia 10, no. 2 (2014): e40-46.

B. D.

James ,

S. E.

Leurgans ,

L. E.

Hebert ,

P. A.

Scherr ,

Yaffe , and

D. A.

Bennett , “Contribution of Alzheimer's Disease to Mortality in the United States,” Neurology 82, no. 12 (2014): 1045-1050.

See Sinclair, supra note 5.

10.

See Id.

11.

SCAN Foundation (2013), “Who Pays for Long-Term Care in the U.S.?”, SCAN Foundation, available at <http://www.thescanfoundation.org/who-pays-long-term-care-us> (last visited July 25, 2018).

12.

Alzheimer's Association, “Tests for Alzheimer's Disease and Dementia,” 2016, available at <http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp> (last visited July 25, 2018).

13.

Wimo and

Prince , World Alzheimer Report 2010: The Global Economic Impact of Dementia (London: Alzheimer's Disease International, 2010).

14.

T. R.

Reid

, “Where's the War on Alzheimer's?” AARP Bulletin, 2015, available at <http://www.aarp.org/health/brain-health/info-2015/alzheimers-research.html> (last visited July 25, 2018).

15.

See Alzheimer's Association, supra note 6.

16.

A. S.

Kelley ,

McGarry ,

Gorges , and

J. S.

Skinner , “The Burden of Health Care Costs for Patients with Dementia in the Last 5 Years of Life,” Annals of Internal Medicine 163, no. 10 (2015): 729-736.

17.

M. D.

Hurd ,

Martorell ,

Delavande ,

K. J.

Mullen , and

K. M.

Langa , “Monetary Costs of Dementia in the United States,” New England Journal of Medicine 368, no. 14 (2013): 1326-1334.

18.

See Reid, supra note 14.

19.

See Kelly et al., supra note 16.

20.

See Bynum, supra note 1.

21.

See Alzheimer's Association, supra note 6.

22.

B. T.

Suehs ,

C. D.

Davis ,

Alvir ,

van Amerongen ,

N. C.

Patel ,

A. V.

Joshi et al., “The Clinical and Economic Burden of Newly Diagnosed Alzheimer's Disease in a Medicare Advantage Population,” American Journal of Alzheimer's Disease and Other Dementias 28, no. 4 (2013): 384-392.

23.

See Sinclair, supra note 5.

24.

J. L.

Wolff ,

Feder , and

Schulz , “Supporting Family Care-givers of Older Americans,” New England Journal of Medicine 375, no. 26 (2016): 2513-2315.

25.

See Reid, supra note 14.

26.

Luengo-Fernandez ,

Leal , and

Gray , “UK Research Spend in 2008 and 2012: Comparing Stroke, Cancer, Coronary Heart Disease and Dementia,” BMJ Open 5, no. 5 (2015): e006648.

27.

Knapton

, “Dementia Research Gets 13 Times Less Funding than Cancer, Figures Show,” 2015, available at <http://www.telegraph.co.uk/news/health/news/11532982/Dementia-research-gets-13-times-less-funding-than-cancer-figures-show.html> (last visited July 25, 2018).

28.

See Alzheimer's Association, supra note 6.

29.

See Hoffman, supra note 4.

30.

Research!America Health Poll, “Top Concerns About Aging: Failing Health, Mental Ability,” 2006, <http://www.researchamerica.org/sites/default/files/uploads/poll2006mental-health.pdf> (last visited July 25, 2018).

31.

M. M.

Gullettemay

, “Our Irrational Fear of Forgetting,” New York Times, 2011, available at <http://www.nytimes.com/2011/05/22/opinion/22gullette.html> (last visited July 25, 2018).

32.

Draper ,

Peisaha ,

Snowdond , and

Brodaty , “Early Dementia Diagnosis and the Risk of Suicide and Euthanasia,” Alzheimer's & Dementia 6, no. 1 (2010): 75-82.

33.

See Gullettemay, supra note 31.

34.

C. M. P. M.

Hertogh

, “End-of-Life Care and Medical Decision Making in Patients with Dementia,” in

Burns

, ed., Standards in Dementia Care: European Dementia Consensus Network (EDCON) (New York: Taylor & Francis, 2005): 339-354.

35.

See Draper, supra note 32.

36.

M. D.

Garrett

, Politics of Anguish: How Alzheimer's Disease Became the Malady of the 21st Century (Createspace, 2015).

37.

Kunkle

, “Alzheimer's Spurs the Fearful to Change Their Lives to Delay It,” Washington Post, 2015, available at <https://www.washingtonpost.com/local/social-issues/fear-of-alzheimers-is-everywhere-but-its-spurring-some-people-to-change-their-lives-for-the-better/2015/07/04/c0600046-192a-11e5-93b7-5eddc056ad8a_story.html> (last visited July 25, 2018).

38.

Telegraph, “Older People are More Scared of Dementia than Cancer, Poll Finds,” 2014, available at <http://www.telegraph.co.uk/news/health/elder/11008905/Older-people-are-more-scared-of-dementia-than-cancer-poll-finds.html> (last visited July 25, 2018).

39.

Gordon

, “Alzheimer's Disease, Media Representations and the Politics of Euthanasia: Constructing Risk and Selling Death in an Ageing Society by Megan-Jane Johnstone (review),” Canadian Journal on Aging / La Revue canadienne du vieillissement 34, no. 2 (2015): 258-260.

40.

See Draper, supra note 32.

41.

M. E.

de Boer ,

M. P. M.

Hertogh ,

Droes ,

I. I.

Riphagen ,

Jonker , and

J. A.

Eefsting , “Suffering from Dementia: The Patient's Perspective,” International Psychogeriatrics 19, no. 6 (2007): 1021-1039.

42.

See Draper, supra note 32.

43.

S. R.

Sabat

, The Experience of Alzheimer's Disease: Life Through a Tangled Veil (Oxford, U.K.: Blackwell Publishers, 2001). Also see

Innes

, Dementia Studies: A Social Science Perspective (London: Sage Publications, 2009).

44.

See Kunkle, supra note 37.

45.

Conrod and

Horwitz , “Marketing of Neuropsychiatric Illness and Enhancement,” in

Chatterjee and

M. J.

Farah , eds., Neuroethics in Practice: Medicine, Mind, and Society (New York: Oxford University Press, 2013): 46-56.

46.

Coveney ,

Gabe , and

Williams , “The Sociology of Cognitive Enhancement: Medicalisation and Beyond,” Health Sociology Review 20, no. 4 (2011): 381-393.

47.

Gilbert and

Ovadia , “Deep Brain Stimulation in the Media: Over-Optimistic Portrayals Call for a New Strategy Involving Journalists and Scientists in Ethical Debates,” Frontiers in Integrative Neuroscience 5, no. 16 (2011): 16.

48.

Id., p.3.

49.

Palmour and

Racine , “Direct-to-Consumer Marketing of Dietary Supplements for Dementia: An Example of Unhealthy Commerce of Neuroscience,” AJOB Neuroscience 2, no. 4 (2011): 30-33.

50.

R. H.

Blank

, Cognitive Enhancement: Social and Public Policy Issues (London: Palgrave, 2015).

51.

Hanrahan

, “Ethical Issues Surrounding Direct-to-Consumer Advertising of Neurotechnology,” Ethics in Biology, Engineering and Medicine: An International Journal 3, nos. 1-3 (2013): 173-84.

52.

Racine ,

H. A.

van Der Loos , and

Illes , “Internet Marketing of Neuroproducts: New Practices and Healthcare Policy Challenges,” Cambridge Quarterly of Healthcare Ethics 16, no. 2 (2007): 181-194.

53.

Bellamy

, “Society for Science-Based Medicine: Comment to FDA on Homeopathic Drug Regulation,” 2015, available at <https://sciencebasedmedicine.org/society-for-science-based-medicine-comment-to-fda-on-homeopathic-drug-regulation/> (last visited July 25, 2018).

54.

Ghoravshi

, “Brain Games Exploit Anxieties about Memory Loss for Profit,” The Guardian, 2014, available at <http://www.theguardian.com/science/2014/oct/23/brain-games-memory-loss-open-letter#sthash.CSyjdlU2.dpuf> (last visited July 25, 2018).

55.

W. R.

Boot and

A. F.

Kramer , “The Brain-games Conundrum: Does Cognitive Training Really Sharpen the Mind?” Cerebrum, 2014, available at <http://dana.org/Cerebrum/2014/The_Brain-Games_Conundrum__Does_Cognitive_Training_Really_Sharpen_the_Mind_/> (last visited August 28, 2018).

56.

Max Planck Institute for Human Development and Stanford Center on Longevity, “A Consensus on the Brain Training Industry from the Scientific Community,” 2014, available at <http://longevity.stanford.edu/a-consensus-on-the-brain-training-industry-from-the-scientific-community-2/> (last visited July 25, 2018).

57.

See Boot and Kramer, supra note 55.

58.

Yuan ,

Tabarak ,

Yu , and

Lei , “Transcranial Direct Current Stimulation in Patients with Alzheimer's Disease: Challenges and Responses,” ADMET & DMPK 3, no. 3 (2015): 235-241.

59.

Cummins

, “Merck Halts Late-Stage Trial of Promising Alzheimer's Drug,” 2017, available at <http://www.cnn.com/2017/02/15/health/merck-alzheimers-drug-trial-fails/index.html> (last visited July 25, 2018).

60.

Hsieh

, “On the Horizon: A Magnetic Zap That Strengthens Memory,” Scientific American Mind 26 (2015): 15.

61.

Mrakic-Sposta ,

Rosa ,

Ferrucci ,

Mameli ,

Vergari , et al., “Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease,” Frontiers in Neuroscience 10, no. 83 (2016): 134.

62.

G. J.

Elder and

J.-P.

Taylor , “Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation: Treatments for Cognitive and Neuropsychiatric Symptoms in the Neurodegenerative Dementias?” Alzheimer's Research and Therapy 6, no. 74 (2014): 74-85.

63.

Cotelli ,

Manenti ,

Brambilla ,

Petesi ,

Rosini ,

Ferrari ,

Zanetti , and

Miniussi , “Anodal tDCS During Face-Name Associations Memory Training in Alzheimer's Patients,” Frontiers in Aging Neuroscience, 2014, available at <https://doi.org/10.3389/fnagi.2014.00038> (last visited July 25, 2018).

64.

Ferrucci ,

Mameli ,

Guidi ,

Mrakic-Sposta ,

Vergari ,

Marceglia ,

Cogiamanian ,

Barbieri ,

Scarpini , and

Priori , “Transcranial Direct Current Stimulation Improves Recognition Memory in Alzheimer Disease,” Neurology 71, no. 7 (2008): 493-498.

65.

P. S.

Boggio ,

L. P.

Khoury ,

D. C.

Martins ,

O. E.

Martins ,

E. C.

de Macedo , and

Fregni , “Temporal Cortex Direct Current Stimulation Enhances Performance on a Visual Recognition Memory Task in Alzheimer Disease,” Journal of Neurology and Neurosurgery Psychiatry 80, no. 5 (2009): 444-447.

66.

Marceglia ,

Mrakic-Sposta ,

Rosa ,

Ferrucci ,

Mameli ,

Vergari ,

Arlotti , et al., “Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease,” Frontiers in Neuroscience, 2016, available at <https://doi.org/10.3389/fnins.2016.00134> (last visited July 25, 2018).

67.

Meinzer ,

Lindenberg ,

M. T.

Phan ,

Ulm ,

Volk , and

Flöel , “Transcranial Direct Current Stimulation in Mild Cognitive Impairment: Behavioral Effects and Neural Mechanisms,” Alzheimer's and Dementia 11, no. 9 (2015): 1032-1040.

68.

Drakos

, “tDCS and Alzheimer's Disease,” Brainstorm Blog (2015), available at <http://www.tdcsbrainstorm.com/brain-stormblog/tdcs-and-alzheimers-disease> (last visited July 25, 2018).

69.

A. W.

Laxton ,

D. F.

Tang-Wai ,

M. P.

McAndrews , et al., “A Phase 1 Trial of Deep Brain Stimulation of Memory Circuits in Alzheimer's Disease,” Annals of Neurology 68 (2010): 521-534;

Dotinga

, “Brain Stimulation Shows Promise against Alzheimer's,” 2014, <http://www.webmd.com/alzheimers/news/20140506/brain-stimulation-shows-early-promise-against-alzheimers#1> (last visited July 25, 2018);

Sauer

, “Benefits of Deep Brain Stimulation for Alzheimer's,” 2016, available at <http://www.alzheimers.net/8-3-15-benefits-of-deep-brain-stimulation-for-alzheimers/> (last visited July 25, 2018).

70.

Novacic

, “Alzheimer's Patients Test Deep Brain Stimulation to Help Boost Memory,” 2016, available at <http://www.cbsnews.com/news/for-alzheimers-patients-new-clinical-trial-could-help-stimulate-memory/> (last visited July 25, 2018); University Health Network, “Deep Brain Stimulation Continues to Show Promise for Patients with Mild Alzheimer's Disease,” ScienceDaily, 2016, available at <www.science-daily.com/releases/2016/07/160719144831.htm> (last visited July 25, 2018).

71.

A. M.

Lozano ,

Fosdick ,

M. M.

Chakravarty ,

J.-M.

Leoutsakos ,

Munro ,

Oh ,

K. E.

Drake ,

C. H.

Lyman ,

P. B.

Rosenberg ,

W. S.

Anderson ,

D. F.

Tang-Wai , et al., “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease,” Journal of Alzheimer's Disease 54, no. 2 (2016): 777-787.

72.

A. W.

Laxton and

A. M.

Lozano , “Deep Brain Stimulation for the Treatment of Alzheimer Disease and Dementias,” World Neurosurgery 80 (2013): S28.e1–S28.e8.

73.

J. M.

Kang ,

B. K.

Yeon ,

S. J.

Cho , and

Y. H.

Suh , “Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials,” Journal of Alzheimer's Disease 54 (2016): 879-889.

74.

Thraves

, “Alzheimer's Society View on Stem Cell Research,” 2015, available at <https://www.alzheimers.org.uk/about-us/policy-and-influencing/what-we-think/stem-cell-research> (last visited August 28, 2018).

75.

StemGenex, “Can Stem Cell Therapy Help Patients with Alzheimer's Disease?” 2016, available at <https://stemgenex.com/studies/alzheimers-stem-cell-studies/?utm_source=bing&utm_medium=cpc&utm_campaign=Alzheimer%27s&utm_content=Stem%20Cell&utm_term=%2Balzheimers%20%2BStem%20%2BCell> (last visited July 25, 2018).

76.

Stem Cell Therapy Plus, 2016, available at <http://www.stemcelltherapyplus.com/> (last visited July 25, 2018).

77.

Harvard Stem Cell Institute, 2016, available at <http://hsci.harvard.edu/alzheimers-disease-0> (last visited July 25, 2018).

78.

Ward ,

Tardiff ,

Dye , and

H.M.

Arrighi , “Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature,” Dementia and Geriatrics Cognitive Disorders Extra 3 (2013): 320-332.

79.

M. E.

Alonso

Vilatela, M. Lopez-Lopez, and

Yescas-Gomez , “Genetics of Alzheimer's Disease,” Archives of Medical Research 43, no. 8 (2012): e622-e631.

80.

E. C.

Hayden

, “Alzheimer's Tests under Fire,” Nature 455, no. 7271 (2008): 30.

81.

Jaret

, “A Test for Alzheimer's Disease Raises Thorny Ethical Issues,” AARP Bulletin, May 2014, available at <http://www.aarp.org/health/brain-health/info-2014/alzheimers-disease-blood-test.html?intcmp=AE-HEA-RELBOX> (last visited July 25, 2018).

82.

Id.

83.

S. D.

Stites ,

Karlawish ,

Harkins ,

J. D.

Rubright , and

Wolk , “Awareness of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia Diagnoses Associated with Lower Self-Ratings of Quality of Life in Older Adults,” Journals of Gerontology, Series B: Psychological Sciences and Social Science 72, no. 6 (2017): 974-985.

84.

Knapton

, “Alzheimer's Disease Could be Prevented after New Blood Test Breakthrough,” 2014, available at <http://www.telegraph.co.uk/news/science/science-news/10951689/Alzheimers-disease-could-be-prevented-after-new-blood-test-breakthrough.html> (last visited July 25, 2018).

85.

M. L.

Baum

, “Patient Requests for Off-Label Bioprediction of Dementia,” Clinical Neuroethics 25, no. 4 (2016): 686-690.

86.

See Alonso Vilatela, supra note 79.

87.

BCBS, Corporate Medical Policy: Genetic Testing for Alzheimer's Disease, 2016, available at <https://www.bcbsnc.com/assets/services/public/pdfs/medicalpolicy/genetic_testing_for_alzheimers_disease.pdf> (last visited July 25, 2018).

88.

For example, see <https://labtestsonline.org/tests/apoegenotyping-alzheimer-disease; https://www.truehealthlabs.com/Apolipoprotein-E-APOE-Test-p/spectracell_apo_e.htm; http://www.insightpharmareports.com/Affiliated-Reports/Global-Data/PharmaFocus--Biomarkers-in-Alzheimer-s-Disease/> (last visited August 28, 2018).

89.

See Hertogh, supra note 34.

90.

Tomlinson and

Stott , “Assisted Dying in Dementia: A Systematic Review of the International Literature on the Attitudes of Health Professionals, Patients, Carers and the Public, and the Factors Associated with These,” International Journal of Geriatric Psychiatry 30 (2014): 10-20.

91.

Alzheimer's Association, End-of-Life Decisions: Honoring the Wishes of a Person with Alzheimer's Disease, 2016, available at <http://www.alz.org/national/documents/brochure_endoflifedecisions.pdf> (last visited July 26, 2018).

92.

Id.

93.

W. J.

Smith

, “Swiss Suicide Clinic Kills Alzheimer's Patient, Euthanasia Activists Applaud,” 2013, available at <http://www.lifenews.com/2013/06/09/swiss-suicide-clinic-kills-alzheimers-patient-euthanasia-activists-applaud/> (last visited July 26, 2018).

94.

See Draper, supra note 32.

95.

Barak and

Aizenberg , “Suicide amongst Alzheimer's Disease Patients: A 10-Year Survey,” Dementia and Geriatric Cognitive Disorders 14, no. 2 (2002): 101-103.

96.

Humphry

, “Can an Alzheimer's Victim End Their Own Life?” 2014, Assisted-Dying Blog, <http://assisted-dying.org/blog/2011/01/10/can-an-alzheimers-victim-end-their-own-life/> (last visited July 26, 2018);

Muramoto

, “Socially and Temporally Extended End-of-Life Decision-Making Process for Dementia Patients,” Journal of Medical Ethics 37, no. 6 (2010): 339-343.

97.

P.V.

Rabins

, “Can Suicide Be a Rational and Ethical Act in Persons with Early or Pre-dementia?” American Journal of Bioethics 7, no. 6 (2007): 47-49.

98.

See Hertogh, supra note 34.

99.

Guidry

, “On the Boundaries of Bioethics: Alzheimer's, Dementia, and Euthanasia,” Applied Sentience, 2014, available at <https://appliedsentience.com/2014/12/19/on-the-boundaries-of-bioethics-alzheimers-dementia-and-euthanasia/> (last visited July 26, 2018).

100.

I.D.

de Beaufort and

van de Vathorst , “Dementia and Assisted Suicide and Euthanasia,” Journal of Neurology 263, no. 7 (2016): 1463-1467.

101.

See Draper, supra note 32.

102.

See de Beaufort, supra note 99.

103.

See Smith, supra note 92.

104.

McCrae

, “Assisted Suicide and Dementia,” 2014, available at <http://www.carenotkilling.org.uk/medical-opinion/assisted-suicide-and-dementia/> (last visited July 26, 2018).

105.

P. S. C.

Kouwenhoven ,

N. J. H.

Raijmakers ,

J. J. M.

van Delden ,

J. A. C.

Rietjens ,

D. G.

van Tol et al., “Opinions about Euthanasia and Advanced Dementia: A Qualitative Study among Dutch Physicians and Members of the General Public,” BMC Medical Ethics 16, no. 7 (2015): 7, available at <http://www.biomedcentral.com/1472-6939/16/7> (last visited July 26, 2018).

106.

McCrae and

Bloomfield , “Mental Health Nursing and the Debate on Assisted Dying,” Journal of Psychiatric & Mental Health Nursing 20 (2013): 655-661.

107.

Prosporo

, “A Patient's Decision: Dementia & Euthanasia,” 2015, available at <https://sozoprosporo.com/2015/12/> (last visited July 12, 2017).

108.

Dong

et al ., “Elder Abuse and Dementia: A Review of the Research and Health Policy,” Health Affairs 33, no. 4 (2014): 642-49.

109.

M.-J.

Johnstone

, Alzheimer's Disease, Media Representations and the Politics of Euthanasia: Constructing Risk and Selling Death in an Ageing Society (Surrey, United Kingdom: Ash-gate, 2013).

110.

R. H.

Blank

, “End-of-Life Decision Making across Cultures,” Journal of Law, Medicine & Ethics 39, no. 2 (2011): 201-214.